Bajaj HealthCare
add_icon

Bajaj HealthCare

309.70
-2.00
(-0.64%)
Market Cap
978.13 Cr
PE Ratio
21.08
Volume
52,722.00
Day High - Low
312.00 - 300.00
52W High-Low
702.10 - 273.25
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
978.13 Cr
EPS
13.29
PE Ratio
21.08
PB Ratio
2.09
Book Value
149.30
EBITDA
101.80
Dividend Yield
0.30 %
Industry
Healthcare
Return on Equity
9.21
Debt to Equity
0.75
Forecast For
Actual

Company News

View All News
Caret
neutral
Anil Champalal Jain converts 4,55,074 convertible warrants into equity shares, increasing his stake from 4.69% to 5.75% in Bajaj Healthcare Limited on March 18, 2026.
neutral
Sajankumar Rameshwarlal Bajaj converts 4,55,074 convertible warrants into equity shares, increasing his shareholding to 36.62% in Bajaj Healthcare Limited.
neutral
Anil Champalal Jain, Managing Director and promoter group member of Bajaj Healthcare Limited, acquired 7,095 equity shares through open market purchase on March 17, 2026, increasing his shareholding to 6.13%.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,683.00
#1 4,03,808.08
37.86
#1 54,729.00
9.71
#1 10,980
16.07
43.28
5,823.50
1,54,595.63
63.26
9,712.00
18.67
2,191
-1.02
35.40
3,976.00
1,34,565.91
61.20
11,539.40
6.99
1,911
26.24
39.04
2,251.00
1,02,880.43
22.26
22,909.50
13.74
3,306
#1 37.44
47.41
1,213.30
1,01,267.24
18.27
33,741.20
16.73
5,725
-15.28
37.62
1,185.90
95,794.71
21.31
28,409.50
7.12
5,291
-57.18
27.34
854.50
85,982.69
#1 17.29
23,511.00
18.55
4,615
-0.32
41.07
1,972.10
81,409.29
45.81
12,744.20
#1 20.90
2,007
7.65
41.64
1,322.70
76,822.63
22.37
32,345.60
9.43
3,484
7.59
66.64
5,178.00
61,910.76
25.87
13,458.30
3.70
2,216
1.90
41.77

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
16.57 %
Net Income Growth
-400.00 %
Cash Flow Change
-76.57 %
ROE
-278.83 %
ROCE
268.16 %
EBITDA Margin (Avg.)
2.84 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
218
223
233
329
371
417
664
681
647
482
562
630
Expenses
190
193
200
288
328
362
521
561
534
397
460
521
EBITDA
29
30
33
41
44
55
143
120
113
85
102
109
Operating Profit %
13 %
13 %
13 %
12 %
12 %
12 %
21 %
17 %
17 %
16 %
15 %
15 %
Depreciation
9
9
11
11
11
12
16
18
17
28
28
27
Interest
8
8
8
8
8
6
8
13
18
30
28
23
Profit Before Tax
12
14
14
23
24
36
119
90
78
-17
46
59
Tax
5
5
6
8
8
11
36
18
15
-2
3
0
Net Profit
8
8
8
15
16
25
83
71
64
-14
43
50
EPS in ₹
11.13
12.15
11.37
22.01
11.82
18.29
30.11
25.87
15.59
-30.36
13.29
15.80

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
189
209
219
268
283
343
526
721
898
765
833
Fixed Assets
109
130
128
127
156
162
208
270
366
253
238
Current Assets
79
78
91
140
124
168
258
398
500
405
485
Capital Work in Progress
1
2
0
2
1
5
57
52
22
7
3
Investments
0
0
0
0
0
5
0
0
0
0
0
Other Assets
79
78
91
140
126
170
261
399
510
506
591
Total Equity & Liabilities
189
209
219
268
283
343
526
721
898
765
833
Current Liabilities
85
88
93
131
111
138
183
322
434
402
272
Non Current Liabilities
22
32
28
23
19
27
85
71
96
85
95
Total Equity
82
89
99
114
153
178
258
329
368
278
466
Reserve & Surplus
78
82
92
107
146
164
245
315
354
265
433
Share Capital
4
7
7
7
7
14
14
14
14
14
16

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-0
1
7
-0
-4
10
-12
16
-16
0
Investing Activities
-17
-31
-8
-12
-13
-28
-109
-75
-93
-11
-15
Operating Activities
28
25
22
17
25
21
44
1
-22
92
22
Financing Activities
-11
5
-13
3
-13
3
76
62
131
-97
-6

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
67.26 %
67.26 %
67.26 %
67.26 %
67.26 %
67.26 %
67.30 %
67.30 %
67.42 %
67.49 %
67.49 %
67.69 %
67.73 %
67.73 %
67.73 %
59.19 %
59.19 %
59.19 %
59.19 %
59.19 %
59.19 %
58.29 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.66 %
0.74 %
0.53 %
0.01 %
1.07 %
1.01 %
1.05 %
1.09 %
1.12 %
1.18 %
1.53 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.34 %
0.34 %
0.34 %
0.44 %
0.48 %
0.44 %
0.00 %
1.97 %
2.36 %
2.52 %
3.16 %
3.00 %
2.96 %
2.91 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
9.79 %
12.67 %
13.95 %
13.95 %
14.85 %
16.53 %
16.71 %
16.50 %
16.67 %
16.45 %
16.80 %
18.44 %
19.45 %
19.91 %
20.17 %
25.52 %
26.94 %
26.72 %
26.63 %
26.24 %
26.62 %
28.50 %
Others
22.94 %
20.06 %
18.79 %
18.79 %
17.89 %
16.21 %
15.99 %
16.21 %
15.57 %
15.73 %
15.37 %
12.78 %
11.61 %
11.39 %
12.09 %
12.26 %
10.50 %
10.52 %
9.93 %
10.45 %
10.05 %
8.76 %
No of Share Holders
7,236
13,283
26,707
31,462
32,309
30,723
30,909
29,769
26,930
26,037
27,322
28,008
29,626
32,712
32,397
31,993
32,672
35,710
35,980
38,574
37,951
37,696

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 2.75 1.5 1 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.81 0.52 0.34 0.15 0.34 0.00

Announcements

Closure of Trading Window8 days ago
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 20, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 20, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 19, 2026
Board Meeting Outcome for Allotment Of Equity Shares Pursuant To Conversion Of Convertible Warrants Into Equity SharesMar 18, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 17, 2026
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 17, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 16, 2026
Board Meeting Intimation for Consideration And Approval Of Allotment Of Equity Shares Upon The Exercise Of Options For The Conversion Of Convertible WarrantsMar 13, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 20, 2026
Announcement Under Regulation 30 (LODR)- UpdatesFeb 02, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 20, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 19, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 18, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 16, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportJan 16, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 16, 2026
Results-Financial Results For December 31 2025Jan 16, 2026
Board Meeting Outcome for Outcome Of The Board MeetingJan 16, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Board Meeting Intimation for Consideration Of Financial ResultsJan 12, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 05, 2026
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Dec 31, 2025
Closure of Trading WindowDec 22, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Dec 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationDec 08, 2025
Announcement Under Regulation 30 (LODR)_Updates (Order From The Honble High Court Gujarat)Dec 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 03, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 27, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 17, 2025
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Oct 17, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportOct 17, 2025
Results-Financial Results For 30/09/2025Oct 17, 2025
Board Meeting Outcome for Outcome Of The Board MeetingOct 17, 2025
Board Meeting Intimation for Consideration Of Financial ResultsOct 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Oct 04, 2025
Shareholder Meeting/Postal Ballot- Voting Results & Scrutinizers ReportSep 29, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2025
Closure of Trading WindowSep 24, 2025
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015- UpdatesSep 24, 2025
Clarification sought from Bajaj Healthcare LtdSep 24, 2025
Corporate Action-Fixes Record Date For Payment Of Final DividendSep 11, 2025
Corporate Action-Board to consider DividendSep 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2025
Intimation Of Letter Sent To ShareholdersSep 04, 2025
Business Responsibility and Sustainability Reporting (BRSR)Sep 04, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.03%
0
0.00%
-0.01%
HDFC Pharma And Healthcare Fund Direct - Growth
0.92%
0
0.00%
-0.13%

Technical Indicators

RSI(14)
Neutral
47.96
ATR(14)
Volatile
16.54
STOCH(9,6)
Neutral
59.60
STOCH RSI(14)
Overbought
82.95
MACD(12,26)
Bullish
2.70
ADX(14)
Weak Trend
22.07
UO(9)
Bearish
45.82
ROC(12)
Uptrend And Accelerating
3.74
WillR(14)
Neutral
-28.73